Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

RADIANCE Trial Investigators. Efficacy

Articles by RADIANCE Trial Investigators. Efficacy

Double-Blinded Extension of the RADIANCE Trial Demonstrates the Efficacy and Safety of Ozanimod in Patients With Multiple Sclerosis

ByCohen JA, Comi G, Arnold DL, et al,RADIANCE Trial Investigators. Efficacy,safety of ozanimod in multiple sclerosis: dose-blinded extension of a randomized phase II study [published online July 25, 2018]. Mult Scler. 2018:1352458518789884. doi: 10.1177/1352458518789884.

January 18th 2019

Latest Updated Articles

Double-Blinded Extension of the RADIANCE Trial Demonstrates the Efficacy and Safety of Ozanimod in Patients With Multiple Sclerosis
January 18th 2019

Trending on AJMC

FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301

New Therapies Offer Hope for Vitiligo, an Often Misunderstood and Undertreated Disease

Andes Hantavirus FAQs: What to Know as Quarantined Cruise Passengers Return Home

Cancer’s Hidden Wound: Trauma From Diagnosis Through Survivorship

Odronextamab Plus CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Matthew Matasar, MD